Table IV. Extracted ion current peak area (mean value ± S.E. (×107)) of new fragments of salivary peptides and proteins showing a significant different concentration between diabetics and controls.
Peptide fragment | Diabetics | Controls | p value |
---|---|---|---|
P-C peptide fr. 1–14 | 1.3 ± 0.3 | 0.7 ± 0.2 | 0.001↑ |
P-C peptide fr. 1–25 | 2.2 ± 0.3 | 1.3 ± 0.3 | 0.003↑ |
P-C peptide fr. 5–25 | 2.4 ± 0.4 | 1.1 ± 0.4 | 0.02↑ |
P-C peptide fr. 15–44 | 1.3 ± 0.2 | 0.7 ± 0.2 | 0.002↑ |
P-C peptide fr. 26–35 | 4.5 ± 0.8 | 2.4 ± 0.7 | 0.01↑ |
P-C peptide fr. 26–44 | 1.5 ± 0.2 | 0.7 ± 0.2 | 0.004↑ |
P-C peptide fr. 36–44 | 8.1 ± 1.1 | 4.1 ± 1.0 | 0.002↑ |
PRP-1/PRP-3 fr. 94–105 | 1.2 ± 0.2 | 0.5 ± 0.1 | 0.0003↑ |
PRP-1 fr. 94–110 | 0.4 ± 0.07 | 0.07 ± 0.02 | 0.0001↑ |
N.I. peptide 559.3 Da | 0.2 ± 0.1 | 0.1 ± 0.02 | 0.03↑ |
N.I. peptide 1237.7 Da | 1.3 ± 0.3 | 0.4 ± 0.1 | 0.02↑ |
N.I. peptide 1238.4 Da | 1.5 ± 0.2 | 0.7 ± 0.2 | 0.0005↑ |
N.I. peptide 2542.3 Da | 0.9 ± 0.2 | 0.4 ± 0.1 | 0.04↑ |
N.I. peptide 2485.9 Da | 0.8 ± 0.1 | 0.4 ± 0.1 | 0.016↑ |
The arrow shows the variation of diabetics vs. controls.